Introduction
============

Organophosphorous (OP) pesticides, a widely used class of insecticides, have been the subject of concern in recent years because of their potential for developmental and neurobehavioral toxicity ([@r3]; [@r9]; [@r20]). Two common OP pesticides, chlorpyrifos and diazinon, were removed from residential pesticide use between 2001 and 2004, largely due to concerns about effects on health ([@r24]); however, applications in agriculture continue. Although use of OP pesticides has declined substantially in recent years, they still accounted for 35% of insecticides applied in the United States in 2007, the latest year for which data are available ([@r12]).

Several OP pesticides have been associated with reduced fetal growth in rodent studies ([@r5]; [@r17]; [@r22]; [@r23]), but studies in humans are inconsistent. Two studies have examined maternal or fetal blood concentrations of OP pesticides ([@r1]; [@r27]), and four studies have looked at maternal urinary concentrations of OP metabolites ([@r11]; [@r19]; [@r26]; [@r28]). Chlorpyrifos concentrations in umbilical cord blood were inversely associated with birth weight and length in a population of low-income, African-American and Dominican women in New York City recruited before the household ban (Columbia cohort) ([@r27]). However, a similar study conducted after the ban found no associations with birth outcome among pregnant women in New Jersey whose chlorpyrifos concentrations were considerably lower than the Columbia study ([@r1]). Dialkyl phosphate (DAP) metabolites of OP pesticides in maternal urine were inversely associated with infant head circumference but not birth weight or length in a racially and economically diverse population of women in New York City (Mount Sinai cohort) ([@r28]). Prenatal urinary DAP metabolites were associated with shorter length of gestation and nonsignificantly increased birth weight, length, and head circumference in a cohort of low-income predominantly Mexican women in California (Center for the Health Assessment of Mothers and Children of Salinas; CHAMACOS cohort) ([@r11]). A study of pregnant women in Cincinnati, Ohio (Health Outcomes and Measures of the Environment; HOME study) found that prenatal urinary DAPs were associated with decreased birth weight in African-American mothers and shorter length of gestation in white mothers ([@r19]). However, a study in Shanghai, China, found no association between maternal urinary DAPs at time of labor and birth weight or length ([@r26]).

Inconsistencies in these findings may be attributable to differences in timing of exposure (e.g., early vs. late pregnancy), measurement of OP exposure (e.g., parent compounds in blood vs. nonspecific DAP metabolites in urine), variability in OP mixtures (e.g., chlorpyrifos or diazinon used residentially vs. a wider range of OP compounds used in agriculture), and patterns of exposure (residential vs. agricultural vs. dietary exposure) across studies. Other challenges to integrating these disparate results include the diverse racial/ethnic compositions of these cohorts, which contribute to differing frequencies of key genetic modifiers, among other sources of heightened susceptibility. For example, paraoxonase (PON) is an enzyme that plays a key role in metabolism and detoxification of some OP pesticides ([@r7]). Paraoxonase levels and efficiency are influenced by several common single nucleotide polymorphisms (SNPs) in the *PON1* gene whose allele frequencies vary significantly in different racial groups ([@r8]). SNPs at the --108 position in the promoter region of the *PON1* gene appear to influence an individual's quantity of the paraoxonase enzyme (subjects with *PON1~--108TT~* genotype have approximately 20% less paraoxonase enzyme), whereas SNPs at the 192 position in the coding region affect the catalytic efficiency of that enzyme in detoxifying OP pesticides with *PON~192QQ~* coding for the enzyme with the lowest efficiency ([@r8]).

To explore relationships between prenatal OP exposure and birth outcomes and potential modification by the *PON1* genotype and race/ethnicity, we pooled data from four previously published longitudinal studies---the CHAMACOS, HOME, Columbia, and Mount Sinai cohorts. We hypothesized that DAP metabolites would be inversely associated with fetal growth, and that this effect would be especially prominent in infants with the susceptible *PON1* genotypes with lower enzyme concentration and catalytic efficiency.

Methods
=======

The study sample combined participants from cohorts that measured urinary DAP metabolites during pregnancy. DAP concentrations from the CHAMACOS, HOME, and Mount Sinai cohorts have been previously reported ([@r11]; [@r19]; [@r28]). DAP concentrations were measured on only a subset of the Columbia cohort and have not been published elsewhere. These four studies were conducted using similar methods, with some key differences ([Table 1](#t1){ref-type="table"}). The CHAMACOS study enrolled low-income women between 1999 and 2000 through prenatal clinics serving the farmworker population of the agricultural Salinas Valley, California ([@r11]). Women were enrolled into the HOME study though prenatal clinics in metropolitan Cincinnati between 2003 and 2006 ([@r19]). The Columbia cohort enrolled African-American and Dominican pregnant women living in northern Manhattan or the South Bronx between 1998 and 2006 ([@r16]; [@r27]), and the Mount Sinai cohort enrolled an ethnically diverse population of primiparous women receiving prenatal care at Mount Sinai Hospital in lower Manhattan between 1998 and 2002 ([@r2]; [@r28]). Major differences between the cohorts were the geographic, racial/ethnic, and socioeconomic characteristics of the populations. Mount Sinai was the only cohort limited to primiparous women. Additionally, the CHAMACOS and HOME cohorts enrolled participants before 20 weeks gestation and obtained two urinary DAP measures (early and late pregnancy), whereas Mount Sinai and Columbia obtained a single DAP measure in the third trimester. In all four cohorts, participants were at least 18 years of age and started prenatal care before 26 weeks gestation.

###### 

Study design of the individual cohorts.

  Design element                       CHAMACOS                                                                                       HOME                                                                                                              Columbia                                                                                                                                                                                                                                          Mount Sinai
  ------------------------------------ ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study location                       Salinas Valley, CA                                                                             Cincinnati, OH                                                                                                    New York, NY                                                                                                                                                                                                                                      New York, NY
  Sample size                          *n*= 486                                                                                       *n*= 344                                                                                                          *n*= 314                                                                                                                                                                                                                                          *n*= 404
  Enrollment years                     1999--2000                                                                                     2003--2006                                                                                                        1998--2006                                                                                                                                                                                                                                        1998--2002
  Mean gestational age at enrollment   14.1 weeks                                                                                     16.1 weeks                                                                                                        33.3 weeks                                                                                                                                                                                                                                        31.8 weeks
  Recruitment sites                    Six prenatal clinics serving farmworkers                                                       Seven prenatal clinics in Cincinnati                                                                              Prenatal clinics at Harlem and NY Presbyterian hospitals                                                                                                                                                                                          Prenatal clinic at Mt. Sinai Hospital
  Eligibility criteria                 ≥ 18 years old\< 20 weeks gestationEnglish or Spanish speakingLow income (Medicaid eligible)   ≥ 18 years old\< 19 weeks gestationLiving in 5 surrounding countiesLiving in home built before 1978HIV negative   18--35 years oldAfrican-American or Dominican identityLiving in Northern Manhattan or South Bronx at least 1 yearFirst prenatal visit \< 20 weeksNo tobacco or drug use in pregnancyNo chronic medical conditions (HIV, diabetes, hypertension)   ≥ 18 years oldPrimiparousFirst prenatal visit ≤ 26 weeksNo alcohol or drug use in pregnancySingleton birthNo chronic medical conditions (diabetes, hypertension) or pregnancy complications
  Race/ethnicity                       Mexican                                                                                        Various                                                                                                           African American and Dominican                                                                                                                                                                                                                    Various

For the main analysis, we excluded women with hypertension, diabetes, and other pregnancy complications that might affect fetal growth; twins and multiple births; stillbirths and neonatal deaths; and women providing urine samples that were dilute (\< 10 mg/dL creatinine). The pooled data set included 1,235 women with urinary DAP measures during pregnancy and birth outcome data from each cohort: 484 women from the CHAMACOS study, 328 women from the HOME study, 82 women from Columbia, and 341 women from Mount Sinai. Informed consent was obtained from all women, and study procedures were approved by the institutional review boards at each research institution.

Data Collection
---------------

In each cohort, mothers were interviewed during pregnancy in their preferred language (English or Spanish). Data collected in common across the four cohorts included demographic information (age, marital status, race, ethnicity, country of birth, educational attainment), behavioral factors (smoking, alcohol, drug use during pregnancy), and pregnancy health (parity, prenatal care use, pregnancy complications). Household income was not collected in one cohort (Mount Sinai) and thus could not be included in the pooled data set; because maternal education level was collected in all cohorts, it was used as a proxy for socioeconomic status.

Infant weight, length, and head circumference at birth were abstracted from medical records at each location. Gestational age at birth was calculated by maternal report of last menstrual period (HOME study) or abstracted from medical records (CHAMACOS, Columbia, Mount Sinai). Because Columbia and Mount Sinai measured OP exposure in a late stage of pregnancy, there was a truncated range in gestational age outcomes and few preterm births in these cohorts, limiting power to detect associations with gestational duration. Thus, gestational age at birth was examined as a covariate in the models of fetal growth, but not as an outcome in the pooled analyses.

Organophosphorous Pesticide Exposure
------------------------------------

In each cohort, spot urine samples were collected from pregnant women at the time of interview. This included two urine samples from women in the CHAMACOS (mean, 13.9 and 26.5 weeks gestation) and HOME (mean, 15.9 and 26.4 weeks gestation) cohorts and one urine collection from women in the Columbia (mean, 33.3 weeks gestation) and Mount Sinai (mean, 31.8 weeks gestation) cohorts. All urinary DAP measurements were conducted by the same laboratory at the Center for Disease Control and Prevention using gas chromatography--tandem mass spectrometry (GC-MS/MS) and quantified using isotope dilution calibration ([@r4]). Limits of detection (LODs) varied among the centers and ranged from 0.1 to 0.7 μg/L (see Table S1). Six individual DAP metabolites were quantified: three dimethyl phosphate (DMP) metabolites (dimethylphosphate, dimethylthiophosphate, dimethyldithiophosphate), derived from OP pesticides such as malathion and dimethoate; and three diethyl phosphate (DEP) metabolites (diethylphosphate, diethylthiophosphate, diethyldithiophosphate), derived from OP pesticides such as chlorpyrifos and diazinon. These DAP metabolites, in units of nanomoles per liter, were summed to yield ΣDMP, ΣDEP, and total ΣDAP for each individual. Many women had concentrations below the LOD for one or more of the metabolites, but only 25 women (2.1%) were below the LOD on all 6 metabolites (see Table S1). In cases where individual metabolite concentrations were below the LOD, the machine-read value was used if available or, if not, a non-zero, random number below the LOD was substituted before the individual DAPs were summed. The random values were selected from all values below the LOD using log-normal probability distributions whose cohort-specific parameters were obtained by maximum likelihood estimation ([@r15]). Summed concentrations (ΣDMP, ΣDEP, and ΣDAP) were truncated at 3 standard deviations below the geometric mean of the pooled data set to avoid influentially low values. Creatinine concentrations in urine, measured using commercially available diagnostic enzyme methods, were used to account for urinary dilution. Creatinine-corrected ΣDMP, ΣDEP, and ΣDAP concentrations were log~10~-transformed for analysis. For the Columbia and Mount Sinai cohorts, the results of the single urinary measurements were used; for the HOME and CHAMACOS studies, the two measurements during pregnancy were averaged. The correlations between the two ΣDAP concentrations during pregnancy were 0.16 and 0.25 for CHAMACOS and HOME, respectively.

*PON1* Genotype
---------------

*PON1~192~* and *PON1~--108~* genotyping was conducted separately at each research center using polymerase chain reaction (PCR)--based methods using umbilical cord blood for children and maternal blood. Genotyping methods have been previously published for the CHAMACOS cohort ([@r14]), the HOME Study ([@r19]), and the Mount Sinai cohort ([@r6]). Mothers and children were genotyped as QQ, QR, or RR for *PON1* ~192~ and TT, CT, or TT for *PON1~--108~.* Maternal *PON1~--108~* genotype was not available from the HOME study, and maternal *PON1~192~* genotype was not available from the HOME or Columbia cohorts.

Data Analysis
-------------

We first compared demographic characteristics and urinary metabolite concentrations across the four cohorts. We examined the associations of urinary ΣDAP, ΣDEP, and ΣDMP concentrations with infant birth weight, length, and head circumference in the pooled data set using multivariable linear regression. We evaluated effect modification by cohort and performed analyses adjusted for and stratified by cohort. We fit mixed-effects models with random slope and intercept, allowing for different associations in each cohort, and with random intercept only. Mixed-effects model estimates for associations between DAP metabolites and the outcomes were similar to estimates from models that did not include random effects for cohort (data not shown), and mixed-effects models did not have significantly better performance based on likelihood ratio tests (α = 0.05), so estimates from mixed-effects models are not reported.

Creatinine-corrected, urinary DAP metabolites were considered as continuous (log~10~ transformed) variables. All models controlled for cohort, sex, self-identified race/ethnicity \[non-Hispanic white, non-Hispanic black, Hispanic (regardless of race), and other\], country of origin (USA vs. other), maternal education (\< high school vs. ≥ high school), parity (primiparous vs. multiparous), smoking during pregnancy (yes vs. no), marital status (married/living together vs. other), and maternal age (continuous) ([Table 2](#t2){ref-type="table"}). Covariate information was missing for 66 women, reducing the final sample size to 1,169 for birth weight, 1,152 for length, and 1,143 for head circumference models. The Hispanic category included women of Mexican, Puerto Rican, Dominican, and other Hispanic descent. To examine fetal growth independent of gestational age, we controlled for gestational age at birth using a cubic spline. We tested for effect modification by race/ethnicity, sex, maternal education, and child *PON1~192~* and *PON1~--108~* genotype by including cross-product interaction terms (e.g. for effect modification of DAPs by the 4-level race/ethnicity variable, we constructed 3 cross-product terms: black × DAPs, Hispanic × DAPs, other × DAPs). We compared models with and without the cross-product terms using Wald tests to examine overall categories of each potential modifier rather than category-by-category tests of interaction. We considered interaction to be statistically significant at α = 0.1. Stratified analyses were conducted according to cohort, race/ethnicity, and maternal and child *PON1* genotype using separate models to obtain stratum-specific estimates. Because of the small size, the race/ethnicity category of "other" was omitted from stratified models, although it was included in the models with interaction terms. *PON1* genotype was the most commonly missing variable, so the sample size was reduced for these interaction models (*n* = 947--953 for infant and *n* = 736--804 for maternal genotype).

###### 

Participant characteristics of the individual cohorts and pooled data set.

  Characteristic                                                                                                                                              Pooled   CHAMACOS         HOME   Columbia         Mount Sinai   *p*-Value^*a*^                                                
  ----------------------------------------------------------------------------------------------------------------------------------------------------------- -------- ---------------- ------ ---------------- ------------- ---------------- ---- ---------------- ----- ---------------- ---------
  Gestational age (weeks)                                                                                                                                     1,235    39.1 ± 1.6       484    38.9 ± 1.7       328           39.2 ± 1.5       82   39.4 ± 1.3       341   39.3 ± 1.5       \< 0.01
  Birth weight (g)                                                                                                                                            1,235    3385.0 ± 514.1   484    3449.7 ± 516.4   328           3407.0 ± 566.3   82   3417.0 ± 470.9   341   3264.1 ± 444.9   \< 0.01
  Length (cm)                                                                                                                                                 1,218    50.6 ± 2.6       478    50.2 ± 2.7       321           51.0 ± 2.8       80   50.9 ± 2.4       339   50.7 ± 2.3       \< 0.01
  Head circumference (cm)                                                                                                                                     1,209    34.0 ± 1.6       468    34.1 ± 1.5       322           34.3 ± 1.8       79   34.0 ± 1.5       340   33.8 ± 1.6       \< 0.01
  Maternal age (years)                                                                                                                                        1,235    25.9 ± 5.9       484    25.9 ± 5.0       328           28.8 ± 5.6       82   24.1 ± 5.1       341   23.4 ± 6.2       \< 0.01
  Prepregnancy BMI (kg/m^2^)                                                                                                                                  1,215    25.6 ± 5.5       484    26.9 ± 5.1       313           26.0 ± 6.3       77   26.0 ± 5.8       341   23.3 ± 4.4       \< 0.01
  Pregnancy weight gain (lb)                                                                                                                                  1,186    32.3 ± 15.3      481    30.0 ± 12.4      324           27.1 ± 13.7      78   37.0 ± 16.9      303   40.2 ± 17.1      \< 0.01
  Child sex                                                                                                                                                                                                                                                                                 
  Male                                                                                                                                                        617      50.0             243    50.2             149           45.4             34   41.5             191   56.0             0.02
  Female                                                                                                                                                      618      50.0             241    49.8             179           54.6             48   58.5             150   44.0             
  Year of birth                                                                                                                                                                                                                                                                             
  1998                                                                                                                                                        60       4.9              0      0.0              0             0.0              0    0.0              60    17.6             \< 0.01
  1999                                                                                                                                                        123      10.0             0      0.0              0             0.0              0    0.0              123   36.1             
  2000                                                                                                                                                        466      37.7             308    63.6             0             0.0              35   42.7             123   36.1             
  2001                                                                                                                                                        258      20.9             176    36.4             0             0.0              47   57.3             35    10.3             
  2003                                                                                                                                                        26       2.1              0      0.0              26            7.9              0    0.0              0     0.0              
  2004                                                                                                                                                        129      10.4             0      0.0              129           39.3             0    0.0              0     0.0              
  2005                                                                                                                                                        122      9.9              0      0.0              122           37.2             0    0.0              0     0.0              
  2006                                                                                                                                                        51       4.1              0      0.0              51            15.5             0    0.0              0     0.0              
  Maternal race/ethnicity                                                                                                                                                                                                                                                                   
  Non-Hispanic white                                                                                                                                          288      23.4             8      1.7              210           64.4             0    0.0              70    20.5             \< 0.01
  Non-Hispanic black                                                                                                                                          220      17.8             0      0.0              94            28.8             35   42.7             91    26.7             
  Hispanic                                                                                                                                                    693      56.2             463    95.7             9             2.8              47   57.3             174   51.0             
  Other                                                                                                                                                       32       2.6              13     2.7              13            4.0              0    0.0              6     1.8              
  Maternal country of origin                                                                                                                                                                                                                                                                
  Other                                                                                                                                                       535      45.0             416    86.0             18            5.5              37   45.1             64    21.6             \< 0.01
  USA                                                                                                                                                         653      55.0             68     14.0             308           94.5             45   54.9             232   78.4             
  Maternal education                                                                                                                                                                                                                                                                        
  Less than high school                                                                                                                                       546      44.3             381    78.7             35            10.7             30   36.6             100   29.4             \< 0.01
  Completed high school                                                                                                                                       686      55.7             103    21.3             291           89.3             52   63.4             240   70.6             
  Marital status                                                                                                                                                                                                                                                                            
  Single                                                                                                                                                      382      31.0             96     19.8             65            19.9             64   78.1             157   46.0             \< 0.01
  Married/living together                                                                                                                                     851      69.0             388    80.2             261           80.1             18   22.0             184   54.0             
  Parity                                                                                                                                                                                                                                                                                    
  Nulliparous                                                                                                                                                 693      56.2             162    33.5             143           43.9             47   57.3             341   100.0            \< 0.01
  Multiparous                                                                                                                                                 540      43.8             322    66.5             183           56.1             35   42.7             0     0.0              
  Smoking during pregnancy                                                                                                                                                                                                                                                                  
  No                                                                                                                                                          1,086    89.4             454    93.8             268           87.0             80   97.6             284   83.3             \< 0.01
  Yes                                                                                                                                                         129      10.6             30     6.2              40            13.0             2    2.44             57    16.7             
  Child *PON*~*--108*~                                                                                                                                                                                                                                                                      
  TT                                                                                                                                                          167      16.9             76     17.6             52            17.9             14   20.6             25    12.6             \< 0.01
  CT                                                                                                                                                          453      45.8             224    52.0             113           38.8             32   47.1             84    42.2             
  CC                                                                                                                                                          369      37.3             131    30.4             126           43.3             22   32.4             90    45.2             
  Child *PON*~*192*~                                                                                                                                                                                                                                                                        
  QQ                                                                                                                                                          300      30.1             108    24.8             117           39.8             14   20.9             61    30.5             \< 0.01
  QR                                                                                                                                                          450      45.2             222    51.0             115           39.1             25   37.3             88    44.0             
  RR                                                                                                                                                          246      24.7             105    24.1             62            21.1             28   41.8             51    25.5             
  Maternal *PON*~*--108*~                                                                                                                                                                                                                                                                   
  TT                                                                                                                                                          165      19.5             103    23.0                           ---              14   20.6             48    14.5             \< 0.01
  CT                                                                                                                                                          374      44.1             218    48.7                           ---              31   45.6             125   37.7             
  CC                                                                                                                                                          309      36.4             127    28.3                           ---              23   33.8             159   47.9             
  Maternal *PON*~*192*~                                                                                                                                                                                                                                                                     
  QQ                                                                                                                                                          220      28.2             125    27.9                           ---                   ---              95    28.6             0.76
  QR                                                                                                                                                          364      46.7             206    46.0                           ---                   ---              158   47.6             
  RR                                                                                                                                                          196      25.1             117    26.1                           ---                   ---              79    23.8             
  BMI, body mass index. ^***a***^*p*-Values for differences across cohorts. *F*-tests for continuous variables, chi-square tests for categorical variables.                                                                                                                                 

After constructing final models, we conducted sensitivity analyses including *a*) limiting analyses to nulliparous women, *b*) limiting to term births, *c*) treating values \< LOD as LOD divided by the square root of 2, *d*) classifying women identifying as Hispanic black (e.g. Dominicans) as black rather than Hispanic, *e*) including women with pregnancy complications such as hypertension and diabetes, *f*) using DAP concentrations that were not corrected for creatinine, and *g*) using only one (late pregnancy) DAP measurement from the HOME and CHAMACOS cohorts. All analyses were conducted in Stata 13.

Results
=======

The four cohorts differed on every characteristic measured, including racial/ethnic composition, country of origin, maternal education, and marital status ([Table 2](#t2){ref-type="table"}). The Columbia cohort was exclusively African American and Hispanic (Dominican); the CHAMACOS cohort predominantly Hispanic (Mexican); the Mount Sinai cohort racially diverse, but predominantly Hispanic (Puerto Rican); and the HOME study cohort largely white. Educational attainment was lowest in the CHAMACOS cohort and highest in the HOME study (21% vs. 89% completing high school, respectively). More women were married or living with their partner in the CHAMACOS and HOME studies (\~ 80%) than in the two New York City studies (54% for Mount Sinai and 22% for Columbia). In the Columbia study, couples were defined as married/living together only if they had lived together at least 7 years, whereas the other studies included all cohabiting couples. Concentrations of urinary metabolites of OP pesticides in each cohort are shown in [Table 3](#t3){ref-type="table"} (see also Figure S1). The geometric mean and median levels of total DAPs were highest in the agricultural CHAMACOS population, similar in the HOME study and Mount Sinai populations, and lowest in the Columbia cohort, despite the fact that the HOME study was the only study to enroll participants after the residential ban on chlorpyrifos (a DEP pesticide). The total DAP concentrations are dominated by DMP metabolites, with concentrations of DMP metabolites about three to four times greater than DEP metabolites.

###### 

Distributions of urinary metabolites of organophosphate pesticides (nmol/g creatinine) measured during pregnancy, by cohort and pooled.

  Cohort                                                                                                                                                                                                                                                                                  *n*     Geometric Mean (SD)   \< LOD (%)   Percentile   Maximum                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- --------------------- ------------ ------------ --------- ------- ------- --------
  CHAMACOS^*a*^                                                                                                                                                                                                                                                                                                                                                             
  Total ΣDAP                                                                                                                                                                                                                                                                              484     105.63 (2.98)         0.0          50.3         102.0     220.9   697.0   3359.8
  ΣDEP                                                                                                                                                                                                                                                                                    484     16.41 (3.07)          0.0          7.8          16.3      34.8    100.6   453.5
  ΣDMP                                                                                                                                                                                                                                                                                    484     76.31 (3.63)          0.0          34.2         78.5      182.3   639.1   3228.9
  HOME^*a*^                                                                                                                                                                                                                                                                                                                                                                 
  Total ΣDAP                                                                                                                                                                                                                                                                              328     66.78 (3.52)          1.6          28.9         70.1      154.2   466.8   1715.4
  ΣDEP                                                                                                                                                                                                                                                                                    328     11.15 (4.47)          16.9         4.5          14.5      31.8    89.3    199.1
  ΣDMP                                                                                                                                                                                                                                                                                    328     44.61 (4.28)          4.8          16.5         46.4      115.1   448.3   1686.8
  Columbia                                                                                                                                                                                                                                                                                                                                                                  
  Total ΣDAP                                                                                                                                                                                                                                                                              82      42.88 (7.44)          7.3          21.3         59.6      135.3   638.0   1622.8
  ΣDEP                                                                                                                                                                                                                                                                                    82      7.39 (13.38)          19.5         4.9          19.4      36.1    110.4   231.8
  ΣDMP                                                                                                                                                                                                                                                                                    82      11.36 (20.63)         25.6         2.9          29.1      110.3   445.4   1584.2
  Mount Sinai                                                                                                                                                                                                                                                                                                                                                               
  Total ΣDAP                                                                                                                                                                                                                                                                              341     75.54 (5.50)          4.1          29.5         77.9      209.0   894.7   8498.6
  ΣDEP                                                                                                                                                                                                                                                                                    341     12.79 (8.96)          14.4         6.9          19.4      52.9    163.1   1629.5
  ΣDMP                                                                                                                                                                                                                                                                                    341     41.10 (7.58)          5.6          13.3         47.3      153.9   760.4   8498.5
  Pooled                                                                                                                                                                                                                                                                                                                                                                    
  Total ΣDAP                                                                                                                                                                                                                                                                              1,235   80.30 (4.14)          2.1          37.1         87.1      199.4   753.1   8498.6
  ΣDEP                                                                                                                                                                                                                                                                                    1,235   13.11 (5.49)          10.2         6.2          16.6      37.5    113.9   1629.5
  ΣDMP                                                                                                                                                                                                                                                                                    1,235   49.15 (5.94)          4.7          20.6         57.2      149.5   631.6   8498.5
  Abbreviations: ΣDAP, dialkyl phosphate metabolites; ΣDEP, diethyl phosphate metabolites; ΣDMP, dimethyl phosphate metabolites. ^***a***^CHAMACOS and HOME urinary metabolites are the average of two pregnancy measurements. Columbia and Mount Sinai are a single pregnancy measure.                                                                                     

No associations were seen between total urinary ΣDAP, ΣDEP, or ΣDMP and birth weight, length, and head circumference in the pooled cohort ([Table 4](#t4){ref-type="table"}). Associations with 10-fold increases in urinary ΣDAP concentrations were close to null for birth weight \[β = 4.47; 95% confidence interval (CI): --35.56, 44.49\], length (β = --0.00; 95% CI: --0.21, 0.22), and head circumference (β = --0.02; 95% CI: --0.16, 0.11). Estimates were similar for 10-fold increase in ΣDEP and ΣDMP metabolites ([Table 4](#t4){ref-type="table"}). Interactions with cohort were not statistically significant for any of the exposures or outcomes (*p*-values ranged from 0.11 to 0.85; [Figure 1](#f1){ref-type="fig"}). Estimates stratified by cohort ([Table 4](#t4){ref-type="table"} and [Figure 1](#f1){ref-type="fig"}) were similar but not identical to those of previously published reports ([@r11]; [@r19]; [@r28]) in which the CHAMACOS cohort tended to show positive trends of urinary OP metabolites with fetal growth while the other cohorts showed negative or null associations. Differences from previously reported results were attributable to slight changes in exclusions, sample size, covariates, correction for urinary dilution, and substitution methods for values \< LOD.

###### 

Associations of 10-fold increases in urinary metabolites of organophosphate pesticides and fetal growth, by individual cohort and pooled data set.

  Cohort, metabolite                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Birth weight (g)   Length (cm)                  Head circumference                                                                          
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ---------------------------- -------------------- ------- ----------------------- ------ ------- ----------------------- ------
  CHAMACOS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Total ΣDAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                484                28.06 (--51.35, 107.46)      0.49                 478     0.15 (--0.30, 0.61)     0.51   468     0.20 (--0.06, 0.46)     0.13
  ΣDEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      484                66.59 (--10.09, 143.26)      0.09                 478     0.22 (--0.22, 0.66)     0.32   468     0.27 (0.01, 0.52)       0.04
  ΣDMP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      484                16.25 (--51.31, 83.82)       0.64                 478     0.10 (--0.29, 0.49)     0.62   468     0.13 (--0.10, 0.35)     0.26
  HOME                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Total ΣDAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                307                --28.29 (--130.43, 73.85)    0.59                 300     --0.03 (--0.55, 0.48)   0.89   301     --0.19 (--0.53, 0.14)   0.26
  ΣDEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      307                --22.84 (--104.18, 58.50)    0.58                 300     --0.04 (--0.44, 0.37)   0.85   301     --0.05 (--0.32, 0.22)   0.70
  ΣDMP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      307                --5.71 (--92.62, 81.19)      0.90                 300     0.02 (--0.42, 0.45)     0.93   301     --0.16 (--0.45, 0.12)   0.27
  Columbia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Total ΣDAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                82                 --10.40 (--124.30, 103.50)   0.86                 80      0.07 (--0.52, 0.67)     0.80   79      --0.26 (--0.61, 0.09)   0.14
  ΣDEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      82                 35.11 (--52.03, 122.26)      0.42                 80      0.33 (--0.13, 0.78)     0.15   79      --0.06 (--0.34, 0.21)   0.65
  ΣDMP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      82                 --34.87 (--109.57, 39.84)    0.35                 80      --0.16 (--0.55, 0.23)   0.41   79      --0.22 (--0.45, 0.02)   0.07
  Mount Sinai                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Total ΣDAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                296                --0.65 (--58.07, 56.76)      0.98                 294     --0.08 (--0.39, 0.23)   0.63   295     --0.08 (--0.30, 0.14)   0.47
  ΣDEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      296                --37.96 (--83.11, 7.18)      0.10                 294     --0.06 (--0.31, 0.18)   0.62   295     0.02 (--0.16, 0.19)     0.86
  ΣDMP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      296                16.21 (--32.73, 65.14)       0.52                 294     --0.05 (--0.31, 0.22)   0.71   295     --0.03 (--0.22, 0.16)   0.74
  Pooled                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Total ΣDAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1,169              4.47 (--35.56, 44.49)        0.83                 1,152   0.00 (--0.21, 0.22)     0.98   1,143   --0.02 (--0.16, 0.11)   0.73
  ΣDEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1,169              1.55 (--31.58, 34.67)        0.93                 1,152   0.06 (--0.12, 0.24)     0.53   1,143   0.04 (--0.07, 0.15)     0.46
  ΣDMP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1,169              2.96 (--29.66, 35.58)        0.86                 1,152   --0.03 (--0.21, 0.15)   0.75   1,143   --0.03 (--0.14, 0.08)   0.59
  Abbreviations: ΣDAP, dialkyl phosphate metabolites; ΣDEP, diethyl phosphate metabolites; ΣDMP, dimethyl phosphate metabolites. All urinary metabolites were creatinine-corrected. CHAMACOS and HOME urinary metabolites are the average of two pregnancy measurements. Models were adjusted for center, sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), country of origin (USA, other), marital status (married/living as married, not married/living as married), maternal education (\< and ≥ high school diploma/equivalent), smoking during pregnancy, parity (nulliparous and multiparous), maternal age at delivery, and gestational age (spline).                                                                                                                                               

![Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight (*A*), length (*B*), and head circumference (*C*) in each cohort and in the pooled data set. Models were adjusted for sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), country of origin (USA, other), marital status (married/living as married, single), maternal education (\< high school, high school graduate), smoking during pregnancy, parity (nulliparous, multiparous), maternal age at delivery, and gestational age (spline). Interaction *p*-values from Wald tests on cross-product terms.](ehp.1409362.g001){#f1}

No statistically significant interaction (α = 0.1) was seen for race/ethnicity ([Figure 2](#f2){ref-type="fig"}), sex (data not shown), or education (data not shown). Although interaction by race/ethnicity was not statistically significant, we present stratified results ([Figure 2](#f2){ref-type="fig"}) for non-Hispanic white, non-Hispanic black, and Hispanic women (women of "other" race/ethnicity were dropped from the analysis due to small numbers) because the HOME study has reported differences in associations of DAP and birth outcome by race/ethnicity. We did find statistically significant interaction for some OP metabolites and *PON1* genotypes, so we present results stratified by child ([Figure 3](#f3){ref-type="fig"}) and maternal (see Figure S2) *PON1* genotype.

![Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight (*A*), length (*B*), and head circumference (*C*) in the pooled data set, stratified by race/ethnicity. Models adjusted for cohort, sex, country of origin (USA, other), marital status (married/living as married, single), maternal education (\< high school, high school graduate), smoking during pregnancy, parity (nulliparous, multiparous), maternal age at delivery, and gestational age (spline). Participants of "other" race/ethnicity not included in figure. Interaction *p*-values from Wald tests on cross-product terms.](ehp.1409362.g002){#f2}

![Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight, length, and head circumference in the pooled data set, stratified by infant *PON~--108~* genotype (*A*--*C*) and infant *PON~192~* genotype (*D*--*F*). Models adjusted for cohort, sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), country of origin (USA, other), marital status (married/living as married, single), maternal education (\< high school, high school graduate), smoking during pregnancy, parity (nulliparous, multiparous), maternal age at delivery, and gestational age (spline). Interaction *p*-values from Wald tests on cross-product terms.](ehp.1409362.g003){#f3}

In models stratified by race/ethnicity ([Figure 2](#f2){ref-type="fig"}), higher concentrations of total ΣDMP were associated with lower infant weight (β = --66.78 g; 95% CI: --137.46, 3.90) and length (β = --0.40 cm; 95% CI: --0.76, --0.04), and ΣDAP were associated with decreased birth length (β = --0.46 cm; 95% CI: --0.91, --0.01) in non-Hispanic black women. When Hispanic blacks (specifically Dominican women in the Columbia cohort) were classified as black rather than Hispanic in sensitivity analyses, the associations between ΣDMP and birth weight (β = --43.63 g; 95% CI: --97.23, 9.97) and length (β = --0.23 cm; 95% CI: --0.51, 0.06) among blacks persisted but were attenuated, and negative associations were also seen with ΣDMP and head circumference (β = --0.18 cm; 95% CI: --0.37, 0.02), although none of the associations was statistically significant.

The distribution of maternal and child *PON1* SNPs differed among the four cohorts ([Table 2](#t2){ref-type="table"}) and was likely related to the differing racial/ethnic composition of the cohorts since *PON1* allele frequencies have been shown to vary by race/ethnicity ([@r21]). Analyses stratified by infant *PON1~--108~* genotype ([Figure 3](#f3){ref-type="fig"}), revealed nonsignificant negative associations of birth weight (β = --60.53 g; 95% CI: --123.59, 2.53) and ΣDEP and of length and ΣDAP (β = --0.33 cm; 95% CI: --0.72, 0.05), ΣDEP (β = --0.27 cm; 95% CI: --0.60, 0.05), and ΣDMP (β = --0.29 cm; 95% CI: --0.62, 0.02) among infants with the *PON1~--108CC~* genotype. In contrast, positive associations of DAPs and birth outcomes were seen among infants with the *PON1~--108TT~* genotype, including a statistically significant positive association of ΣDMP and length (β = 0.47 cm; 95% CI: 0.03, 0.91). Interaction terms for genotype × DAPs were statistically significant in the models of ΣDEP on birth weight (*p* = 0.08) and ΣDAP and ΣDMP on length (*p* = 0.07 and *p* = 0.02, respectively). With infant *PON1~192~* genotype, we observed negative associations of length and ΣDAP (β = --0.42 cm; 95% CI: --0.89, 0.04; *p* ~interaction~ = 0.25) and ΣDMP (β = --0.46 cm; 95% CI: --0.86, --0.06; *p* ~interaction~ = 0.14) among the *RR* group. Positive associations were seen with head circumference and ΣDAP (β = --0.23 cm; 95% CI: --0.02, 0.47; *p* ~interaction~ = 0.05) and ΣDMP (β = --0.15 cm; 95% CI: --0.03, 0.33; *p* ~interaction~ = 0.11) among the heterozygous *QR* group. No statistically significant associations were seen for DAPs and birth outcome stratifying by maternal *PON1* genotype (see Figure S2), except for a positive association of total ΣDEP and head circumference (β = 0.31 cm; 95% CI: 0.07, 0.55; *p* ~interaction~ = 0.13) in mothers with the *PON1~192QR~* genotype. Interaction terms for genotype × DAPs were statistically significant in the models of ΣDAP and ΣDMP on head circumference (*p* = 0.09 for both), again with positive associations seen in the heterozygous *PON1~192QR~* genotype, although no associations were statistically significant. Maternal *PON1~192~* genotype was not available for Columbia participants, and no maternal *PON1* genotypes were available for HOME participants.

In sensitivity analyses, results did not change substantively when the sample was limited to primiparous women (*n* = 638) or term births (*n* = 1,090) or when women with pregnancy complications (*n* = 103) were included (data not shown). Results were also similar when the DAP concentrations were uncorrected for creatinine, when values \< LOD were assigned LOD divided by the square root of 2, and when only one late pregnancy measure of urinary metabolites was used for each woman (data not shown).

Discussion
==========

We found no significant associations between metabolites of OP pesticides and birth weight, length, and head circumference in a pooled data set of \> 1,000 pregnant women from four birth cohort studies. Animal studies suggest that OPs may restrict fetal growth, possibly by influencing the adenylyl cyclase signaling cascade, by increasing thyroxine levels, or by effects on placental transport of nutrients ([@r10]). However, previously published results from these four birth cohorts ([@r11]; [@r19]; [@r27]; [@r28]) showed associations between OP exposure and birth outcome that were inconsistent across studies. However, we did observe inverse associations of DAP and DM metabolites with birth length and nonsignificant inverse associations of DM metabolites with birth weight among black women. This is consistent with findings of decreased birth weight with increasing DAP, DE, and DM concentrations among black women in the HOME study ([@r19]) and decreased birth weight and length with increasing blood concentrations of chlorpyrifos in African-American and Dominican women in the Columbia study ([@r27])---although it should be noted that chlorpyrifos devolves to DEP metabolites ([@r4]), and the main association seen in blacks in this study was with DMPs.

We hypothesized that we might see inverse associations of urinary OP metabolites with birth outcomes in mothers or children with the more vulnerable *PON1~--108TT~* and *PON1~192QQ~* genotypes. In the Mount Sinai cohort, DEP metabolites were associated with significantly lower birth weight among mothers with the *PON1~192QQ~* genotype ([@r28]). In the CHAMACOS study, the inverse associations of DAPs with gestational duration were strongest among infants with *PON1~--108TT~* and *PON1~192QQ~* genotypes ([@r13]). However, this pattern was not seen in the HOME cohort, where decrements in birth weight and gestational age associated with DAP were greatest among infants with heterozygous *PON1~--108CT~* and *PON1~192QR~* genotypes ([@r19]). In the pooled analysis, birth weight was negatively associated with total DEPs in infants with the *PON1* ~--108~ *~CC~* genotype, and birth length was negatively associated with both DAP and DMP metabolites among infants with the *PON1* ~--108~ *~CC~* and *PON1* ~192~ *~RR~* genotypes, rather than the less active *PON1* ~--108~ *~TT~* and *PON1* ~192~ *~QQ~* genotypes, as hypothesized. We found limited interaction of DAPs with maternal *PON1* genotype, and the patterns of association did not support stronger negative associations among women with the more susceptible genotypes, even though maternal genotype might be hypothesized to be the more powerful determinant of susceptibility than infant genotype given that mothers have approximately four times the paraoxonase enzyme as newborns and have a 50% overlap with infant genotype ([@r14]). We had fewer observations for the maternal genotype analysis because HOME study participants did not have maternal genotype data for either SNP, and Columbia study participants had data for only one; however, there was little or no evidence of consistent patterns of association, as might be expected if the only issue was reduced precision. Thus, it is possible that the patterns with infant genotype were attributable to chance. An additional issue is that *PON1* allele frequencies vary by race/ethnicity, as can be seen in the different SNP distributions across cohorts. Because race/ethnicity is associated with birth outcome and *PON1* genotype and may also be associated with OP exposure, confounding by race/ethnicity is a possibility. Although we controlled for race/ethnicity in the models, there is considerable genetic variability within race/ethnicity categories (perhaps especially among the Hispanic category, which included women of Mexican, Puerto Rican, and Dominican origin), suggesting that we cannot completely discount the possibility of residual confounding.

In addition to racial and ethnic differences, the cohorts also varied in sources and routes of OP pesticide exposures, including food, home pesticide use, and agricultural drift or take-home exposure. Thus, urinary DAP concentrations may reflect different exposures in each cohort, limiting their interpretation in the pooled data set. In the farmworker CHAMACOS population, urinary DAPs likely represented a combination of agricultural, residential, and dietary exposure, a different mix of pesticides than would be experienced by the low-income, urban Columbia and Mount Sinai populations who were presumably exposed only through residential and dietary routes, or the more affluent HOME study participants who were enrolled after the residential ban and likely exposed mainly through diet. The HOME participants had relatively high DAP levels considering that their exposure was mainly dietary, suggesting that they may have had higher fruit and vegetable consumption, a very different route of exposure than women who may be exposed from home pesticide use.

Not all of the six urinary DAPs were equally detected. The proportion of women with values below the detection limit in the pooled sample ranged from 9% for DMTP to 78% for DEDTP. Individual OPs do not necessarily devolve to all three DE or DM metabolites---for example, malathion devolves to DMP, DMTP (dimethylthiophosphate), and DMDTP (dimethyldithiophosphate), whereas oxydemeton-methyl devolves only to DMP and DMTP ([@r4])---and it is expected that certain metabolites have lower detection frequencies than others. For this reason, we examined ΣDEP and ΣDMP metabolites to obtain comprehensive estimates of exposure to all DE- and DM-devolving OP pesticides. However, the large number of women with concentrations \< LOD for some metabolites may have resulted in minor misclassification at the very lowest exposure levels. Misclassification of these minimal exposures would not be expected to seriously bias the exposure--response estimation across the full range of exposure.

Although urinary DAPs are a useful biomarker of OP pesticide exposure, they have limitations. OPs have short half-lives in the body and show considerable intra-individual variability over time; thus, urinary DAPs represent short-term rather than ongoing exposure. DAPs are nonspecific metabolites, and not all pesticides that devolve to the same metabolite are equally toxic; for example, both oxydemeton-methyl and malathion devolve to DMP metabolites, but the former is much more toxic ([@r25]). Although we can determine whether the parent pesticide was from the DEP or DMP class, we cannot determine the mix of actual pesticide parent compounds to which the mother was exposed. Thus, we cannot examine how the toxicity of the pesticide mixture differed across cohorts. Additionally, OPs can break down to DAPs in the environment as well as in the body, so DAP concentrations in urine reflect a mixture of exposure to toxic parent compounds and nontoxic preformed DAPs in dust and food ([@r18]). The proportion of preformed DAPs may be greater in populations receiving their exposure predominantly from food, where the parent pesticide has had more time to break down into DAPs before consumption. Finally, although DAP concentrations were all measured in the same laboratory using the same analytical methods, samples were stored for different amounts of time and analysis took place in different years. Thus, we cannot rule out the possibility of storage or batch effects, suggesting that, although rank order of DAP concentrations is internally consistent within cohort, rank may not be accurate when DAP concentrations measured in different batches (i.e. cohorts) are pooled together.

One strength of this study is its large sample size, which allows for better examination of race/ethnicity and genetic variability than in the more homogenous, individual cohorts. Methodologies were similar between cohorts and tests of interaction by cohort failed to reject the hypothesis of homogeneity by cohort. Analyses in our pooled cohort confirmed earlier findings of associations of OP exposure (as measured by DAPs in urine and chlorpyrifos in blood) with decreased birth weight in non-Hispanic black women, but not in whites or Hispanics ([@r19]; [@r27]). In general, non-Hispanic black women had a wider range and more variability in birth weight, which may explain why an association was seen in this group.

Overall, this study does not support associations of OP pesticide exposure during pregnancy with decreased weight, length, or head circumference at birth, except in black women and possibly infants with the *PON1~--108CC~* and *PON1~192RR~* genotypes. However, this study also illustrates the limitations of pooling data when the population demographics and exposure patterns for biomarkers of exposure with a short half-life differ across cohorts. Although pooling data from multiple cohorts is tempting, careful consideration must be given to the interpretation of the exposure measures in each cohort and whether rank order is maintained and remains meaningful across the pooled cohort. In some cases, individual cohort studies with homogeneous populations may be preferable to pooled data.

**Editor's Note:** In the Advance Publication, the symbols in the figure legends for [Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"} were incorrect. In the [Figure 2A--C](#f2){ref-type="fig"} legends, the correct symbols are triangles to indicate "Non-Hispanic Black" and circles to indicate "Hispanic." In the [Figure 3A--C](#f3){ref-type="fig"} legends, the correct symbols are triangles to indicate "CT" and circles to indicate "CC." In the [Figure 3D--F](#f3){ref-type="fig"} legends, the correct symbols are triangles to indicate "QR" and circles to indicate "RR." The correct figure legends are included in this article.
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